Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Infinium Pharmachem's Other Operating Expense for the
six
months ended in Mar. 2026 was ₹109 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹226 Mil.
Infinium Pharmachem's quarterly Other Operating Expense
declined
from Mar. 2025 (₹140 Mil) to Sep. 2025 (₹116 Mil) and
declined
from Sep. 2025 (₹116 Mil) to Mar. 2026 (₹109 Mil).
Infinium Pharmachem's annual Other Operating Expense
increased
from Mar. 2024 (₹146 Mil) to Mar. 2025 (₹204 Mil) and
increased
from Mar. 2025 (₹204 Mil) to Mar. 2026 (₹226 Mil).
Infinium Pharmachem Other Operating Expense Related Terms
Infinium Pharmachem Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Infinium Pharmachem's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹226 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ₹226 Mil mean?
Infinium Pharmachem (NSE:INFINIUM) has a Other Operating Expense of ₹226 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Infinium Pharmachem and its competitors.
Is Infinium Pharmachem's Other Operating Expense too high?
Infinium Pharmachem's current Other Operating Expense is ₹226 Mil. Overall, Infinium Pharmachem has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Infinium Pharmachem's Other Operating Expense compare to DOW?
Infinium Pharmachem's Other Operating Expense of ₹226 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Chemicals company?
A good Other Operating Expense depends on the Chemicals industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Infinium Pharmachem and its competitors. Infinium Pharmachem's current Other Operating Expense is ₹226 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Infinium Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Infinium Pharmachem (NSE:INFINIUM) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹310.31, compared to a current price of ₹263.00 — trading 15.2% below its estimated fair value. The current Other Operating Expense is ₹226 Mil. Infinium Pharmachem's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Infinium Pharmachem (NSE:INFINIUM), the current Other Operating Expense is ₹226 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Infinium Pharmachem (NSE:INFINIUM) Overvalued in 2026?
Based on GuruFocus' analysis, Infinium Pharmachem stock appears to be undervalued.
The current stock price of ₹263.00 is trading 15.2% below its estimated GF Value™ of ₹310.31.
GuruFocus considers Infinium Pharmachem to be Modestly Undervalued.
Key valuation signals for NSE:INFINIUM:
Other Operating Expense: ₹226 Mil
GF Value™: ₹310.31 vs. price of ₹263.00 (15.2% below fair value)
No single metric tells the full story. See the NSE:INFINIUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.
85GF Score
Get the complete analysis for NSE:INFINIUM
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INFINIUM has been successfully added to your 
